© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.